Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer

Head and Neck

Volumn 33, Issue 11, 2011, Pages 1551-1556

  Dragovic, Aleksandar F ^a   Bonner, James A ^a   Spencer, Sharon A ^a   Nabell, Lisle M ^b   Carroll, William R ^c   Caudell, Jimmy J ^a,d  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

altered fractionation; AWD; chemotherapy; head and neck cancer; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054030685     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21634     Document Type: Article

References (24)

1. Fletcher GH,. Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol 1973; 46: 1-12.
2. Withers HR, Peters LJ, Taylor JM, et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995; 33: 549-562.
3. Maciejewski B, Preuss-Bayer G, Trott KR,. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321-328. (Pubitemid 13055174)
4. Baclesse F,. Fractionated roentgenotherapy of epitheliomas of the pharynx, larynx, uterus, vagina and breast; study of 1449 cases. [Article in French] Acta Unio Int Contra Cancrum 1953; 9: 29-33.
5. Million RR, Parsons JT, Cassisi NJ,. Twice-a-day irradiation technique for squamous cell carcinomas of the head and neck. Cancer 1985; 55 (9 Suppl): 2096-2099. (Pubitemid 15119172)
6. Peters LJ, Ang KK, Thames HD Jr,. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 1988; 27: 185-194.
7. Wang CC, Blitzer PH, Suit HD,. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55 (9 Suppl): 2100-2104. (Pubitemid 15119173)
8. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003; 362: 933-940. (Pubitemid 37159288)
9. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16. (Pubitemid 30488207)
10. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843-854. (Pubitemid 44292807)
11. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R,. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys 2003; 56: 573-585. (Pubitemid 36546258)
12. Lauve A, Morris M, Schmidt-Ullrich R, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II - clinical results. Int J Radiat Oncol Biol Phys 2004; 60: 374-387. (Pubitemid 39233454)
13. Salama JK, Seiwert TY, Vokes EE,. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 2007; 25: 4118-4126. (Pubitemid 47492956)
14. Pignon JP, le Maitre A, Maillard E, Bourhis J,; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
15. Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA,. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 76: 403-409.
16. Kaplan E, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
17. Mantel N,. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
18. Cox DR,. Regression models and life-tables (with discussion). J R Stat Soc (B) 1972; 34: 187-220.
19. Bourhis J, Sire C, Lapeyre M, et al. Accelerated versus conventional radiotherapy with concomitant chemotherapy in locally advanced head and neck carcinomas: results of a phase III randomized trial. American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting, Abstract-67, 2008.
20. Ang K, Pajak T, Wheeler R, et al. A phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): report of efficacy and toxicity. American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting, Abstract-LB 2, 2009.
21. Vokes EE, Stenson K, Rosen FR, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003; 21: 320-326. (Pubitemid 46606162)
22. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 2009; 101: 142-152.
23. Bonner JA, Sloan JA, Shanahan TG, et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 1999; 17: 2681-2691. (Pubitemid 29415224)
24. Bonner JA, McGinnis WL, Stella PJ, et al. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced non small cell lung carcinoma: results of a North Central Cancer Treatment Group (NCCTG) Phase III Study. Cancer 1998; 82: 1037-1048. (Pubitemid 28136515)